T1DM therapy is based on self-monitoring, i.e., glycaemia monitoring, insulin adjustment, handling hypoglycaemia and hyperglycaemia, counting quantities of carbohydrates consumed by a patient and remembering factors that influence the level of glycaemia, such as physical activity, hormones, stress and temperature. The gene discussed is INS; the disease is type 1 diabetes mellitus.